Anti-IL-6 Receptor Antibody Suppresses Adhesion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for suppressing postoperative adhesion formation are inadequate, as they often interfere with wound healing or lack effectiveness in preventing adhesion formation after surgical procedures.
Innovation Solution
The use of an anti-IL-6 receptor antibody, administered preoperatively, which suppresses neutrophil migration to the surgical site without affecting wound healing, thereby reducing postoperative adhesion formation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If conventional methods are used to suppress postoperative adhesion formation, then adhesion prevention is improved, but wound healing is suppressed
Solution Approach 1:
The patent uses anti-IL-6 receptor antibody as an intermediary substance that specifically targets and blocks the IL-6 signaling pathway. This mediator selectively inhibits adhesion formation by preventing neutrophil migration through the IL-6 receptor, while leaving other wound healing pathways intact. The antibody acts as a precise biological mediator that distinguishes between adhesion-related processes and normal wound repair mechanisms.
Solution Approach 2:
The patent changes the biological parameter by introducing exogenous anti-IL-6 receptor antibody that binds to and neutralizes the IL-6 receptor. This parameter change specifically reduces neutrophil migration to the surgical site by blocking the IL-6 signaling pathway, thereby suppressing adhesion formation without affecting other aspects of wound healing that depend on different cytokine pathways.
2Object-affected harmful factors
If adhesion suppression is enhanced, then postoperative complications are reduced, but effectiveness in preventing adhesion formation is insufficient with current methods
Solution Approach 1:
The anti-IL-6 receptor antibody serves as a specific intermediary that targets the IL-6 signaling pathway, which is a key mediator in adhesion formation. By blocking this specific pathway, the patent achieves reliable adhesion prevention with reduced postoperative complications such as intestinal obstruction and infertility, overcoming the insufficiency of conventional non-specific methods.
3Object-affected harmful factors
If neutrophil migration is suppressed, then adhesion formation is reduced, but wound healing may be affected
Solution Approach 1:
The anti-IL-6 receptor antibody acts as a selective intermediary that specifically blocks neutrophil migration by inhibiting the IL-6 receptor pathway. This targeted approach reduces adhesion formation by preventing excessive neutrophil accumulation while preserving wound healing processes that rely on other cytokine pathways and cell types, thus avoiding the trade-off between adhesion suppression and wound repair.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The anti-IL-6 receptor antibody effectively suppresses adhesion formation by reducing neutrophil migration to the surgical site, as demonstrated in mouse models, without impairing wound healing, providing a novel approach to prevent postoperative adhesions.
Implementation Method 1
an anti-IL-6 receptor antibody... suppresses neutrophil migration
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Postoperative adhesion formation at an invasion site and migration of neutrophils to the site of surgical invasion are suppressed by administering an anti-IL-6 receptor antibody and/or a neutrophil-neutralizing antibody.